GNFT

Genfit (GNFT)

Genfit SA

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GNFT

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
05/29/2024	3:10PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
05/22/2024	11:06AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
05/14/2024	3:10PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
01/17/2024	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
01/11/2024	3:10PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
11/16/2023	3:10PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
11/09/2023	3:10PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
11/06/2023	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
09/05/2023	3:10PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
07/12/2023	3:10PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
05/31/2023	3:44PM	PR Newswire (US)	Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT for Development of Injectable Formulation of SRT-015 for Acute-on-Chronic Liver Disease (ACLF)	NASDAQ:GNFT	Genfit SA
05/31/2023	3:16PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
05/24/2023	2:00PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
05/11/2023	3:11PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
05/09/2023	3:11PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
05/05/2023	5:07AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GNFT	Genfit SA
05/01/2023	3:01PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GNFT	Genfit SA
04/28/2023	5:17AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
04/18/2023	12:58PM	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:GNFT	Genfit SA
01/05/2023	3:11PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
11/17/2022	3:10PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
11/10/2022	3:11PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
10/25/2022	3:11PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
09/29/2022	3:11PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
09/29/2022	7:35AM	TipRanks	H.C. Wainwright Sticks to Their Buy Rating for Genfit SA (GNFT)	NASDAQ:GNFT	Genfit SA
09/19/2022	5:11AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
07/08/2022	3:16PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
05/25/2022	3:12PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
04/29/2022	3:26PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
04/27/2022	8:44AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA